Related Experiment Video
Updated: Jul 11, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Harnessing the post-vaccination era: Do emerging HPV types represent a new threat?
Sergio Ponce-de-Leon1, Marcela Lizano2
1Unidad de Epidemiología Clínica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Col. Belisario Domínguez, Tlalpan, Mexico City 14080, Mexico.
The human papillomavirus (HPV) vaccine is effective, but this study investigated if other HPV types could emerge as threats. Researchers found no evidence of this after analyzing HPV types 8 years post-vaccination.
Area of Science:
- Epidemiology
- Virology
- Public Health
Background:
- The human papillomavirus (HPV) vaccine is highly effective at preventing infections.
- Concerns exist regarding potential niche-occupancy by non-targeted HPV types post-vaccination.
- Long-term epidemiological data on HPV type distribution following vaccination policies are limited.
Purpose of the Study:
- To analyze the community-level epidemiological impact of HPV vaccination on HPV type distribution.
- To investigate the potential for non-targeted HPV types to emerge as a threat.
- To assess HPV type dynamics up to 8 years after the implementation of different vaccination strategies.
Main Methods:
- Community-level epidemiological analysis.
- Longitudinal study design tracking HPV types.
- Analysis of data up to 8 years post-vaccination policies.
Main Results:
- The study found no evidence of non-targeted HPV types emerging to fill niches left by vaccine-targeted types.
- HPV type distribution remained stable with no significant increase in previously uncommon types.
- The findings suggest the HPV vaccine does not lead to compensatory increases in other HPV types.
Conclusions:
- The HPV vaccine does not appear to create ecological niches for other HPV types to emerge.
- Current vaccination policies are not associated with an increased risk from untargeted HPV types.
- The long-term safety and efficacy of the HPV vaccine in terms of viral ecology are supported by these findings.
More Related Videos
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...

